Literature DB >> 30613056

[Types of Perception toward Ethical Issues in Perioperative Nurses: Q-Methodological Approach].

Jin Nam Kim1, Seok Hee Jeong2.   

Abstract

PURPOSE: This study was aimed at identifying the types of perceptions of ethical issues among perioperative nurses.
METHODS: Q-methodology focusing on individual subjectivity was used with data collected in November 2016. Thirty-four Q-statements were selected and scored by the 35 participants on a 9-point scale with normal distribution. Participants were perioperative nurses working in advanced general hospitals and general hospitals. The data were analyzed using the PC-QUANL program.
RESULTS: total of 35 perioperative nurses were classified into 4 factors based on the following viewpoints: self-centered (type 1), onlooking and avoiding (type 2), patient-centered (type 3), and problem-centered (type 4). The 4 factors accounted for 57.84% of the total variance. Individual contributions of factors 1, 2, 3, and 4 were 41.80%, 7.18%, 5.20%, and 3.66%, respectively.
CONCLUSION: The major contribution of this study is the clarification of perioperative nurses' subjective perceptions of ethical issues. These findings can be used in formulating effective strategies for nursing educators, professional nurses, and nursing administrators to improve ethical decision-making abilities and to perform ethical nursing care by the appropriate management of ethical issues in everyday nursing practice.
© 2018 Korean Society of Nursing Science.

Entities:  

Keywords:  Nurses; Nursing Ethics; Perception; Perioperative Nursing; Q-Sort

Mesh:

Year:  2018        PMID: 30613056     DOI: 10.4040/jkan.2018.48.6.679

Source DB:  PubMed          Journal:  J Korean Acad Nurs        ISSN: 2005-3673            Impact factor:   0.984


  1 in total

1.  The Psychological Responses of Nurses Caring for COVID-19 Patients: A Q Methodological Approach.

Authors:  Kyung Hyeon Cho; Boyoung Kim
Journal:  Int J Environ Res Public Health       Date:  2021-03-31       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.